Talha Aijaz, M.D.
Department of General Oncology, Division of Cancer Medicine
About Dr. Talha Aijaz
Dr. Aijaz is board certified in Internal Medicine. He is a distinguished and compassionate hematologist and oncologist dedicated to diagnosing, treating, and caring for patients facing hematologic and oncologic disorders. Dr. Aijaz obtained his MS degree in Clinical Research from Rush University in Chicago. He then went on to complete his MBBS at Allama Iqbal Medical College in Pakistan. He completed his Residency in Internal Medicine at Cook County Health in Chicago followed by a Fellowship in Hematology and Oncology at the University of Louisville. Dr. Aijaz is an accomplished researcher in the field of Hematology-Oncology. He has published numerous research papers in respected medical journals focusing on head and neck cancer and blood disorders.
Read More
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Galveston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Galveston, TX
Education & Training
Degree-Granting Education
| 2020 | Rush University, Chicago, Illinois, US, Master of Science in Clinical Research |
| 2014 | Allama Iqbal Medical College, Lahore, PK, MBBS in Bachelor of Medicine - Bachelor of Surgery |
Postgraduate Training
| 2020-2023 | Clinical Fellowship, Hematology/Oncology, University of Louisville, Louisville, Kentucky |
| 2017-2020 | Clinical Residency, Internal Medicine, Cook County Health, Chicago, Illinois |
Board Certifications
| 2020 | American Board of Internal Medicine |
Honors & Awards
| 2012 | Chief Minister Youth Initiative Award |
| 2010 | AIMCANA Scholarship |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Katiyar V, Aijaz T, Lingamaneni P, Vohra I, Cisak K. Polycythemia in a Patient with Atonic Bladder and Hydronephrosis. Cureus 13(9):e18094, 2021. e-Pub 2021. PMID: 34692308.
Abstracts
- Tariq A, Aijaz T, Katiyar V. Role of Anticoagulation and IVIG in Treatment of Vaccine-Induced Thrombotic Thrombocytopenia (VITT). Blood, 140(Supplement 1),. American Society of Hematology 140(1):None, 2022. PMID: None.
- Tariq A, Aijaz T, Katiyar V, Rojan A. Effect of Transition from Inpatient Oncology Service to Oncology Consult Service on Fellow Burn Out and Training. American Society of Clinical Oncology 40(16):None, 2022. PMID: None.
- Katiyar V, Sidhu J, Do Q, Wu X, Rai S, Aijaz T, Tariq A, Singh V. Prognostic Value of Hematologic Parameters in Patients with Muscle Invasive Bladder Cancer. American Society of Clinical Oncology 40(16):None, 2022. PMID: None.
- Tariq A, Katiyar V, Aijaz T. Safety of Anti-CD-19 Chimeric Antigen Receptor T-Cell Therapy in the Older Population with Diffuse Large B Cell Lymphoma: A Meta-Analysis. American Society of Hematology 138(Supplement 1):None, 2021. PMID: None.
- Aijaz T, Obi ON, Khokhar N, Lingamaneni P, Farooq MZ. Safety and Efficacy of Direct Oral Anticoagulants in Morbidly Obese Patients: A Meta-Analysis. American Society of Hematology 134(None):None, 2019. PMID: None.
Patient Reviews
CV information above last modified October 02, 2024